NDLI: Bias and inconsistency in the estimation of tumour mutation burden

Content Provider	Springer Nature : BioMed Central
Author	Makrooni, Mohammad A. O’Sullivan, Brian Seoighe, Cathal
Abstract	Background Tumour mutation burden (TMB), defined as the number of somatic mutations per megabase within the sequenced region in the tumour sample, has been used as a biomarker for predicting response to immune therapy. Several studies have been conducted to assess the utility of TMB for various cancer types; however, methods to measure TMB have not been adequately evaluated. In this study, we identified two sources of bias in current methods to calculate TMB. Methods We used simulated data to quantify the two sources of bias and their effect on TMB calculation, we down-sampled sequencing reads from exome sequencing datasets from TCGA to evaluate the consistency in TMB estimation across different sequencing depths. We analyzed data from ten cancer cohorts to investigate the relationship between inferred TMB and sequencing depth. Results We found that TMB, estimated by counting the number of somatic mutations above a threshold frequency (typically 0.05), is not robust to sequencing depth. Furthermore, we show that, because only mutations with an observed frequency greater than the threshold are considered, the observed mutant allele frequency provides a biased estimate of the true frequency. This can result in substantial over-estimation of the TMB, when the cancer sample includes a large number of somatic mutations at low frequencies, and exacerbates the lack of robustness of TMB to variation in sequencing depth and tumour purity. Conclusion Our results demonstrate that care needs to be taken in the estimation of TMB to ensure that results are unbiased and consistent across studies and we suggest that accurate and robust estimation of TMB could be achieved using statistical models that estimate the full mutant allele frequency spectrum.
Related Links	https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-022-09897-3.pdf
Ending Page	9
Page Count	9
Starting Page	1
File Format	HTM / HTML
ISSN	14712407
DOI	10.1186/s12885-022-09897-3
Journal	BMC Cancer
Issue Number	1
Volume Number	22
Language	English
Publisher	BioMed Central
Publisher Date	2022-08-02
Access Restriction	Open
Subject Keyword	Cancer Research Oncology Surgical Oncology Health Promotion and Disease Prevention Biomedicine Medicine Public Health Tumour mutation burden Variant allele frequency Tumour heterogeneity Medicine/Public Health
Content Type	Text
Resource Type	Article
Subject	Cancer Research Oncology Genetics
Journal Impact Factor	3.4/2023
5-Year Journal Impact Factor	3.8/2023

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

A novel somatic mutation in ACD induces telomere lengthening and apoptosis resistance in leukemia cells

Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients

Genetic variability in CYP3A4 and CYP3A5in primary liver, gastric and colorectal cancer patients

Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma

Clinical application of liquid biopsy in cancer patients

The neoepitope landscape of breast cancer: implications for immunotherapy

Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups

MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis

Bias and inconsistency in the estimation of tumour mutation burden

Similar Documents

A novel somatic mutation in ACD induces telomere lengthening and apoptosis resistance in leukemia cells

Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients

Genetic variability in CYP3A4 and CYP3A5in primary liver, gastric and colorectal cancer patients

Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma

Clinical application of liquid biopsy in cancer patients

The neoepitope landscape of breast cancer: implications for immunotherapy

Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups

MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis

Bias and inconsistency in the estimation of tumour mutation burden